CAH
Cardinal Health, Inc. NYSE Listed Aug 4, 1983$221.90
After hrs
$221.77
+0.00%
Mkt Cap $52.0B
52w Low $137.75
87.8% of range
52w High $233.60
50d MA $203.60
200d MA $196.92
P/E (TTM)
35.1x
EV/EBITDA
18.9x
P/B
—
Debt/Equity
-3.4x
ROE
-56.5%
P/FCF
29.0x
RSI (14)
81.70
ATR (14)
$4.98
Beta
0.65
50d MA
$203.60
200d MA
$196.92
Avg Volume
2.5M
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
7000 Cardinal Place · Dublin, OH 43017 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | TNS | 2.79 | 3.17 | +13.6% | 192.88 | +1.8% | +1.2% | +0.9% | -0.0% | -2.8% | -3.2% | — |
| Feb 5, 2026 | TNS | 2.34 | 2.63 | +12.4% | 227.18 | -0.4% | -0.4% | -0.2% | -2.4% | +1.8% | -4.1% | — |
| Oct 30, 2025 | TNS | 2.18 | 2.55 | +17.0% | 189.84 | +1.2% | +0.5% | -0.3% | +2.7% | +0.7% | +0.6% | — |
| Aug 12, 2025 | TNS | 2.04 | 2.08 | +2.0% | 146.30 | +0.9% | +1.2% | +1.4% | -0.4% | +0.1% | -0.5% | — |
| May 1, 2025 | TNS | 2.17 | 2.35 | +8.3% | 145.53 | +1.2% | +2.7% | +1.6% | -0.2% | +1.2% | -4.0% | — |
| Jan 30, 2025 | TNS | 1.74 | 1.93 | +10.9% | 128.26 | -1.1% | -3.6% | +1.4% | -0.1% | +1.8% | -0.3% | — |
| Nov 1, 2024 | TNS | 1.62 | 1.88 | +16.0% | 116.13 | +0.8% | -3.6% | +1.1% | +2.1% | +2.3% | +2.0% | — |
| Aug 14, 2024 | TNS | 1.73 | 1.84 | +6.4% | 106.36 | -1.3% | +1.5% | +1.8% | -0.1% | -0.8% | +0.7% | — |
| May 2, 2024 | TNS | 1.95 | 2.08 | +6.7% | 102.98 | -1.3% | -4.0% | -0.3% | +1.1% | -2.3% | +0.6% | — |
| Feb 1, 2024 | TNS | 1.60 | 1.82 | +13.8% | 105.10 | +0.7% | -1.6% | +0.2% | +0.4% | +1.5% | -2.8% | — |
| Nov 3, 2023 | TNS | 1.40 | 1.73 | +23.6% | 100.21 | -0.7% | +1.4% | +1.3% | -0.7% | +0.5% | +1.3% | — |
| Aug 15, 2023 | TNS | 1.48 | 1.55 | +4.7% | 90.57 | -0.0% | -0.2% | -4.4% | -0.6% | +1.3% | -1.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Citigroup | Maintains | Buy → Buy | — | $192.88 | $196.37 | +1.8% | +1.2% | +0.9% | -0.0% | -2.8% | -3.2% |
| May 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $192.88 | $196.37 | +1.8% | +1.2% | +0.9% | -0.0% | -2.8% | -3.2% |
| May 1 | TD Cowen | Maintains | Buy → Buy | — | $192.88 | $196.37 | +1.8% | +1.2% | +0.9% | -0.0% | -2.8% | -3.2% |
| Apr 28 | William Blair | Initiates | Outperform | — | $202.34 | $204.73 | +1.2% | +1.6% | -1.4% | -4.9% | +1.2% | +0.9% |
| Apr 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $212.77 | $213.19 | +0.2% | +1.1% | +0.3% | -0.1% | -0.6% | +0.4% |
| Feb 24 | Barclays | Maintains | Overweight → Overweight | — | $224.82 | $224.52 | -0.1% | +0.5% | +0.1% | +0.4% | +0.9% | +0.3% |
| Feb 10 | JP Morgan | Maintains | Neutral → Neutral | — | $225.76 | $226.00 | +0.1% | -2.4% | +1.8% | -4.1% | +2.7% | +2.2% |
| Feb 10 | Wells Fargo | Maintains | Overweight → Overweight | — | $225.76 | $226.00 | +0.1% | -2.4% | +1.8% | -4.1% | +2.7% | +2.2% |
| Feb 6 | Mizuho | Maintains | Outperform → Outperform | — | $227.18 | $226.21 | -0.4% | -0.4% | -0.2% | -2.4% | +1.8% | -4.1% |
| Jan 29 | Morgan Stanley | Maintains | Overweight → Overweight | — | $210.39 | $212.46 | +1.0% | +0.4% | +1.7% | +1.9% | -0.4% | -5.1% |
| Jan 15 | Wells Fargo | Maintains | Overweight → Overweight | — | $213.56 | $213.65 | +0.0% | -0.0% | -0.5% | -1.0% | -0.9% | -0.8% |
| Jan 9 | Citigroup | Upgrade | Neutral → Buy | — | $202.49 | $203.79 | +0.6% | -0.7% | +0.7% | +2.8% | +2.5% | -0.0% |
| Nov 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $195.34 | $196.50 | +0.6% | +0.7% | +0.6% | +2.9% | +0.9% | -0.3% |
| Nov 4 | Mizuho | Maintains | Outperform → Outperform | — | $190.22 | $190.43 | +0.1% | +2.7% | +0.7% | +0.6% | +2.9% | +0.9% |
| Nov 3 | TD Cowen | Maintains | Buy → Buy | — | $190.77 | $191.07 | +0.2% | -0.3% | +2.7% | +0.7% | +0.6% | +2.9% |
| Oct 31 | UBS | Maintains | Buy → Buy | — | $189.84 | $192.07 | +1.2% | +0.5% | -0.3% | +2.7% | +0.7% | +0.6% |
| Oct 31 | Evercore ISI | Maintains | Outperform → Outperform | — | $189.84 | $192.07 | +1.2% | +0.5% | -0.3% | +2.7% | +0.7% | +0.6% |
| Oct 31 | Citigroup | Maintains | Neutral → Neutral | — | $189.84 | $192.07 | +1.2% | +0.5% | -0.3% | +2.7% | +0.7% | +0.6% |
| Aug 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $146.30 | $147.63 | +0.9% | +1.2% | +1.4% | -0.4% | +0.1% | -0.5% |
| Aug 13 | Evercore ISI | Maintains | Outperform → Outperform | — | $146.30 | $147.63 | +0.9% | +1.2% | +1.4% | -0.4% | +0.1% | -0.5% |
| Aug 13 | Baird | Maintains | Outperform → Outperform | — | $146.30 | $147.63 | +0.9% | +1.2% | +1.4% | -0.4% | +0.1% | -0.5% |
| Aug 12 | Leerink Partners | Maintains | Outperform → Outperform | — | $157.66 | $141.00 | -10.6% | -7.2% | +1.2% | +1.4% | -0.4% | +0.1% |
| Jul 16 | Morgan Stanley | Maintains | Overweight → Overweight | — | $161.02 | $161.44 | +0.3% | +0.1% | -1.0% | +0.1% | -0.6% | -0.9% |
| Jun 13 | Citigroup | Maintains | Neutral → Neutral | — | $160.52 | $161.32 | +0.5% | +0.6% | +0.6% | +1.5% | +0.3% | -1.2% |
| Jun 13 | Morgan Stanley | Maintains | Overweight → Overweight | — | $160.52 | $161.32 | +0.5% | +0.6% | +0.6% | +1.5% | +0.3% | -1.2% |
| Jun 12 | Evercore ISI | Maintains | Outperform → Outperform | — | $153.53 | $155.10 | +1.0% | +4.6% | +0.6% | +0.6% | +1.5% | +0.3% |
| Jun 10 | BofA Securities | Maintains | Buy → Buy | — | $153.62 | $153.79 | +0.1% | -0.4% | +0.3% | +4.6% | +0.6% | +0.6% |
| Jun 3 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $155.25 | $156.80 | +1.0% | +0.1% | -0.9% | +0.0% | +0.4% | -0.7% |
| Jun 2 | Evercore ISI | Maintains | Outperform → Outperform | — | $154.44 | $154.21 | -0.1% | +0.5% | +0.1% | -0.9% | +0.0% | +0.4% |
| May 5 | Morgan Stanley | Maintains | Overweight → Overweight | — | $149.53 | $150.69 | +0.8% | +1.6% | -0.2% | +1.2% | -4.0% | +0.6% |
| May 2 | Baird | Maintains | Outperform → Outperform | — | $145.53 | $147.28 | +1.2% | +2.7% | +1.6% | -0.2% | +1.2% | -4.0% |
| May 2 | UBS | Maintains | Buy → Buy | — | $145.53 | $147.28 | +1.2% | +2.7% | +1.6% | -0.2% | +1.2% | -4.0% |
| May 1 | Citigroup | Maintains | Neutral → Neutral | — | $141.29 | $140.01 | -0.9% | +3.0% | +2.7% | +1.6% | -0.2% | +1.2% |
| Apr 29 | UBS | Maintains | Buy → Buy | — | $138.24 | $138.24 | +0.0% | +1.2% | +1.0% | +3.0% | +2.7% | +1.6% |
| Apr 17 | Citigroup | Maintains | Neutral → Neutral | — | $134.36 | $133.66 | -0.5% | +0.3% | -2.6% | +1.9% | +0.6% | +1.0% |
| Apr 11 | BofA Securities | Maintains | Buy → Buy | — | $128.88 | $128.61 | -0.2% | +2.2% | +2.3% | -0.4% | +0.1% | +0.3% |
| Mar 31 | Mizuho | Maintains | Outperform → Outperform | — | $136.44 | $136.34 | -0.1% | +1.0% | -0.5% | +1.1% | -1.1% | -5.4% |
| Feb 5 | Jefferies | Upgrade | Hold → Buy | — | $125.17 | $127.02 | +1.5% | +1.8% | -0.3% | +0.3% | -0.1% | +0.9% |
| Feb 4 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $125.33 | $123.57 | -1.4% | -0.1% | +1.8% | -0.3% | +0.3% | -0.1% |
| Feb 4 | JP Morgan | Maintains | Neutral → Neutral | — | $125.33 | $123.57 | -1.4% | -0.1% | +1.8% | -0.3% | +0.3% | -0.1% |
| Jan 31 | Citigroup | Maintains | Neutral → Neutral | — | $128.26 | $126.80 | -1.1% | -3.6% | +1.4% | -0.1% | +1.8% | -0.3% |
| Jan 31 | Morgan Stanley | Maintains | Overweight → Overweight | — | $128.26 | $126.80 | -1.1% | -3.6% | +1.4% | -0.1% | +1.8% | -0.3% |
| Jan 29 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $127.73 | $128.50 | +0.6% | +0.0% | +0.4% | -3.6% | +1.4% | -0.1% |
| Jan 24 | JP Morgan | Maintains | Neutral → Neutral | — | $129.30 | $129.47 | +0.1% | -0.4% | +1.5% | -2.3% | +0.0% | +0.4% |
| Jan 10 | Citigroup | Maintains | Neutral → Neutral | — | $122.53 | $121.82 | -0.6% | -0.8% | -0.6% | +2.6% | +0.5% | +1.9% |
| Jan 8 | TD Cowen | Upgrade | Hold → Buy | — | $121.40 | $122.65 | +1.0% | +0.9% | -0.8% | -0.6% | +2.6% | +0.5% |
| Jan 7 | Evercore ISI | Upgrade | In Line → Outperform | — | $119.63 | $120.67 | +0.9% | +1.5% | +0.9% | -0.8% | -0.6% | +2.6% |
| Jan 6 | BofA Securities | Upgrade | Neutral → Buy | — | $119.30 | $121.41 | +1.8% | +0.3% | +1.5% | +0.9% | -0.8% | -0.6% |
| Dec 17 | Morgan Stanley | Maintains | Overweight → Overweight | — | $116.55 | $115.87 | -0.6% | -0.6% | +0.1% | +0.9% | +1.1% | +0.1% |
| Dec 13 | Wells Fargo | Upgrade | Underweight → Equal Weight | — | $117.46 | $118.81 | +1.1% | +0.5% | -1.3% | -0.6% | +0.1% | +0.9% |
No insider trades available.
8-K · 7.01
! Medium
Cardinal Health, Inc. -- 8-K 7.01: Regulation FD Disclosure
Cardinal Health executives will present Q3 2026 earnings results and fiscal year guidance via webcast on April 30, 2026, providing investors an opportunity to assess the company's operational performance and forward-looking strategy.
Apr 30
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Vafa Jamali's appointment as director signals potential strategic shifts in governance and decision-making, warranting investor attention to board composition changes affecting corporate direction and oversight quality.
Apr 6
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Cardinal Health (CAH) appointed a new CFO, signaling potential strategic shifts in financial management and operational efficiency that could impact investor confidence in company direction and capital allocation decisions.
Mar 31
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Cardinal Health's appointment of Patricia A. Hemingway Hall as Board Chair signals leadership stability and potential strategic direction, likely reassuring investors about governance quality and future decision-making at the healthcare distributor.
Mar 23
8-K · 5.02
!!! Very High
Cardinal Health, Inc. -- 8-K 5.02: Executive Change
Cardinal Health's Chief Accounting Officer Mary Scherer is departing, triggering a leadership transition that investors should monitor for potential accounting function disruptions during the successor search.
Mar 5
8-K
Albertsons Companies, Inc. -- 8-K Filing
I need more complete information to provide analysis. The summary provided appears truncated and doesn't clarify what action Albertsons took (appointment, departure, partnership, etc.) or how it impacts investors—please provide the full summary.
Feb 27
8-K · 7.01
! Medium
Cardinal Health, Inc. -- 8-K 7.01: Regulation FD Disclosure
Cardinal Health executives will discuss Q2 2026 earnings results and updated fiscal guidance during a February 5 webcast, providing investors with near-term performance insights and forward-looking outlook.
Feb 5
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 15,288,709 | $3.2B | New | Mar 2026 |
| 2 | Vanguard Portfolio Management Llc | 13,732,309 | $2.9B | New | Mar 2026 |
| 3 | Morgan Stanley | 10,245,376 | $2.1B | Reduced | Dec 2025 |
| 4 | Fmr Llc | 4,243,240 | $897M | Reduced | Mar 2026 |
| 5 | Invesco Ltd. | 3,512,241 | $742M | Added | Mar 2026 |
| 6 | Bank Of America Corp /de/ | 2,881,765 | $609M | Reduced | Mar 2026 |
| 7 | Northern Trust Corp | 2,794,307 | $590M | Reduced | Mar 2026 |
| 8 | Citadel Advisors Llc | 2,332,238 | $493M | Added | Mar 2026 |
| 9 | Jpmorgan Chase & Co | 2,316,644 | $478M | Reduced | Mar 2026 |
| 10 | Acadian Asset Management Llc | 1,736,431 | $367M | Added | Mar 2026 |
| 11 | Aqr Capital Management Llc | 1,589,770 | $332M | Added | Mar 2026 |
| 12 | Bnp Paribas Financial Markets | 1,503,897 | $318M | Reduced | Mar 2026 |
| 13 | Voya Investment Management Llc | 1,436,619 | $295M | Added | Dec 2025 |
| 14 | Victory Capital Management Inc | 1,386,834 | $293M | Reduced | Mar 2026 |
| 15 | Bank Of New York Mellon Corp | 1,359,624 | $287M | Reduced | Mar 2026 |
| 16 | Sg Americas Securities, Llc | 1,147,406 | $242M | Added | Mar 2026 |
| 17 | Qube Research & Technologies Ltd | 1,012,309 | $214M | Reduced | Mar 2026 |
| 18 | Robeco Institutional Asset Management B.v. | 1,011,356 | $214M | Added | Mar 2026 |
| 19 | Barclays Plc | 993,914 | $210M | Reduced | Mar 2026 |
| 20 | Royal Bank Of Canada | 952,686 | $201M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$51.97B
Enterprise Value
$58.71B
P/E (TTM)
35.08x
Forward P/E
21.49x
PEG Ratio
0.30x
P/B
—
P/S
0.24x
P/FCF
29.03x
EV/EBITDA
18.90x
Shares Out
242.0M
Financials (TTM)
Revenue
$222.58B
Net Income
$1.56B
EBITDA
$3.11B
Free Cash Flow
$1.85B
Op Cash Flow
$2.40B
EPS Basic
$6.48
EPS Diluted
$6.45
EPS Forward
$10.32
Gross Margin
3.7%
Op Margin
1.0%
Net Margin
0.7%
Balance Sheet
Total Assets
$53.12B
Total Liab.
$55.76B
Total Equity
-$2.63B
Cash
$3.87B
LT Debt
$7.82B
Book Value/Sh
$-10.93
Debt/Equity
-3.36x
Current Ratio
0.94
Quick Ratio
0.50
Returns & Growth
ROE
-56.5%
ROA
2.8%
ROIC
11.4%
Rev Growth YoY
-1.9%
EPS Growth YoY
+86.2%
Price Returns
2W
+1.2%
1M
+2.0%
3M
-14.1%
6M
-7.3%
12M
+27.4%
Technicals
52W High
$233.60
52W Low
$137.75
50d MA
$203.60
200d MA
$196.92
RSI (14)
81.70
ATR (14)
$4.98
Beta
0.65
Avg Volume
2.5M
Dividends
Div Rate
$2.05
Div Yield
1.1%
Frequency
4
Ex-Div Date
Apr 1, 2026
Analyst Price Targets
Consensus
$250.11
High
$275.00
Low
$220.00
Median
$255.00
Data updated apr 24, 2026 11:41pm
· Source: financialmodelingprep.com